Gila Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
A Dose Escalating Study to Assess the Safety and Tolerability of GT-001
- First Posted Date
- 2018-04-06
- Last Posted Date
- 2018-04-06
- Lead Sponsor
- Gila Therapeutics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03490786
- Locations
- 🇺🇸
Orange County Research Center, Tustin, California, United States
© Copyright 2025. All Rights Reserved by MedPath